Skip to main content
. Author manuscript; available in PMC: 2021 May 28.
Published in final edited form as: Nat Rev Dis Primers. 2020 Aug 13;6(1):68. doi: 10.1038/s41572-020-0196-7

Fig. 1 ∣. Worldwide prevalence of podocytopathies.

Fig. 1 ∣

a ∣ Worldwide prevalence of podocytopathy with minimal change lesions (MCLs). b ∣ Worldwide prevalence of podocytopathy with focal segmental glomerulosclerosis (FSGS) lesions. Data are expressed as a percentage of total kidney biopsies and were obtained from international registries8,9,254-262.